TRIM37 and cancer: The ability of TRIM37 to prevent the formation of ectopic PLK4-containing aggregates is particularly important in the context of cells lacking functional centrosomes, suggesting for example that TRIM37 could trigger selective mitotic failure in cancer types sensitive to PLK4 inhibition.